Cyanidin-3-O-Glucoside improves the viability of human islet cells treated with amylin or Aβ1-42 in vitroJennifer Croden, Gina R. Rayat|PLoS ONE|2021Cited by 11
<i>MECOM</i> fusion partner and bone marrow blast percentage influence outcomes of patients with <i>MECOM</i> rearranged acute myeloid leukaemiaWei‐Ying Jen, Tapan M. Kadia, Guillermo Montalban‐Bravo et al.|British Journal of Haematology|2025Cited by 3